Product Information
REXULTI 2 MG TABLET is a brand product labeled by Otsuka America Pharmaceutical Inc., priced at $49.5847 per EA under NDC 59148003813. Its NADAC has been published 549 times since Dec 23, 2015.
Strength
2 mg/1
Manufacturer
Otsuka America Pharmaceutical Inc.NDC
59148003813
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BREXPIPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA205422On Market Since
7/10/2015
Pharmacological Classes
Price Statistics
The NADAC for REXULTI 2 MG TABLET has been published 549 times since Dec 23, 2015, and over the history we have for it it has risen 76.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.5847 per EA |
|---|---|
| All-time high | $49.6092 (Jun 10, 2026) |
| All-time low | $27.8673 (Jan 20, 2016) |
| 52-week high | $49.6092 |
| 52-week low | $48.2779 |
| Median price | $39.8101 |
| Average price | $39.6936 |
| Largest weekly change | +9.9% (Apr 11, 2018) |
| Weeks tracked | 549 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the brexpiprazole market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of REXULTI 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REXULTI 2 MG TABLET, manufactured by Otsuka America Pharmaceutical Inc., is $49.5847 per EA (NDC 59148003813), effective Jun 24, 2026.
How has the price of REXULTI 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for REXULTI 2 MG TABLET has risen 76.8%. It has been tracked across 549 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for REXULTI 2 MG TABLET?
Since Dec 23, 2015, the NADAC for REXULTI 2 MG TABLET has ranged from a low of $27.8673 (Jan 20, 2016) to a high of $49.6092 (Jun 10, 2026), with a median of $39.8101 per EA.
Are there cheaper alternatives to REXULTI 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of REXULTI 2 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures REXULTI 2 MG TABLET?
REXULTI 2 MG TABLET (NDC 59148003813) is labeled by Otsuka America Pharmaceutical Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification